Carlsson, P. & Mahlapuu, M. Forkhead transcription factors: key players in development and metabolism. Dev. Biol. 250, 1–23 (2002).
Lehmann, O.J., Sowden, J.C., Carlsson, P., Jordan, T. & Bhattacharya, S.S. Fox's in development and disease. Trends Genet. 19, 339–344 (2003).
Nehls, M., Pfeifer, D., Schorpp, M., Hedrich, H. & Boehm, T. New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature 372, 103–107 (1994).
Lin, L., Spoor, M.S., Gerth, A.J., Brody, S.L. & Peng, S.L. Modulation of Th1 activation and inflammation by the NF-κB repressor Foxj1. Science 303, 1017–1020 (2004).
Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).
Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330–336 (2003).
Khattri, R., Cox, T., Yasayko, S.A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337–342 (2003).
Li, C. & Tucker, P.W. DNA-binding properties and secondary structural model of the hepatocyte nuclear factor 3/fork head domain. Proc. Natl. Acad. Sci. USA 90, 11583–11587 (1993).
Shu, W., Yang, H., Zhang, L., Lu, M.M. & Morrisey, E.E. Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J. Biol. Chem. 276, 27488–27497 (2001).
Wang, B., Lin, D., Li, C. & Tucker, P. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J. Biol. Chem. 278, 24259–24268 (2003).
Banham, A.H. et al. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res. 61, 8820–8829 (2001).
Banham, A.H. et al. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin. Cancer Res. 11, 1065–1072 (2005).
Streubel, B., Vinatzer, U., Lamprecht, A., Raderer, M. & Chott, A.T. (3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 19, 652–658 (2005).
Liu, P. et al. Bcl11a is essential for normal lymphoid development. Nat. Immunol. 4, 525–532 (2003).
Busslinger, M. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22, 55–79 (2004).
Singh, H., Medina, K.L. & Pongubala, J.M. Contingent gene regulatory networks and B cell fate specification. Proc. Natl. Acad. Sci. USA 102, 4949–4953 (2005).
Scott, E.W. et al. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity 6, 437–447 (1997).
Georgopoulos, K. et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79, 143–156 (1994).
Hagman, J., Travis, A. & Grosschedl, R. A novel lineage-specific nuclear factor regulates mb-1 gene transcription at the early stages of B cell differentiation. EMBO J. 10, 3409–3417 (1991).
Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885–892 (1994).
Zhuang, Y., Soriano, P. & Weintraub, H. The helix-loop-helix gene E2A is required for B cell formation. Cell 79, 875–884 (1994).
Lin, H. & Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263–267 (1995).
Urbanek, P., Wang, Z.Q., Fetka, I., Wagner, E.F. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901–912 (1994).
Horcher, M., Souabni, A. & Busslinger, M. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14, 779–790 (2001).
Karasuyama, H., Kudo, A. & Melchers, F. The proteins encoded by the VpreB and λ5 pre-B cell-specific genes can associate with each other and with μ heavy chain. J. Exp. Med. 172, 969–972 (1990).
Romanow, W.J. et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5, 343–353 (2000).
Fuxa, M. et al. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 18, 411–422 (2004).
Schatz, D.G., Oettinger, M.A. & Baltimore, D. The V(D)J recombination activating gene, RAG-1. Cell 59, 1035–1048 (1989).
Oettinger, M.A., Schatz, D.G., Gorka, C. & Baltimore, D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248, 1517–1523 (1990).
Yu, W. et al. Coordinate regulation of Rag1 and Rag2 by cell type-specific DNA elements 5′ of Rag2. Science 285, 1080–1084 (1999).
Yu, W. et al. Continued Rag expression in late stages of B cell development and no apparent re-induction after immunization. Nature 400, 682–687 (1999).
Wang, B. et al. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development 131, 4477–4487 (2004).
Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D. & Hayakawa, K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173, 1213–1225 (1991).
Tsubata, T. & Reth, M. The products of pre-B cell-specific genes (λ5 and VpreB) and the immunoglobulin μ chain form a complex that is transported onto the cell surface. J. Exp. Med. 172, 973–976 (1990).
Melchers, F. Fit for life in the immune system? Surrogate L chain tests H chains that test L chains. Proc. Natl. Acad. Sci. USA 96, 2571–2573 (1999).
Goebel, P. et al. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J. Exp. Med. 194, 645–656 (2001).
Hsu, L.Y. et al. A conserved transcriptional enhancer regulates Rag gene expression in developing B cells. Immunity 19, 105–117 (2003).
Nardone, J., Lee, D.U., Ansel, K.M. & Rao, A. Bioinformatics for the 'bench biologist': how to find regulatory regions in genomic DNA. Nat. Immunol. 5, 768–774 (2004).
Davidson, W.F., Pierce, J.H., Rudikoff, S. & Morse, H.C., III. Relationships between B cell and myeloid differentiation. Studies with a B lymphocyte progenitor line, HAFTL-1. J. Exp. Med. 168, 389–407 (1988).
Wu, G.E. & Paige, C.J. VH gene family utilization in colonies derived from B and pre-B cells detected by the RNA colony blot assay. EMBO J. 5, 3475–3481 (1986).
Connor, A.M. et al. Mouse VH7183 recombination signal sequences mediate recombination more frequently than those of VHJ558. J. Immunol. 155, 5268–5272 (1995).
Rolink, A. et al. In-vitro analyses of mechanisms of B-cell development. Semin. Immunol. 7, 155–167 (1995).
Bain, G. et al. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6, 145–154 (1997).
O'Riordan, M. & Grosschedl, R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11, 21–31 (1999).
Hirose, J. et al. A developing picture of lymphopoiesis in bone marrow. Immunol. Rev. 189, 28–40 (2002).
Sagara, S. et al. B220 expression by T lymphoid progenitor cells in mouse fetal liver. J. Immunol. 158, 666–676 (1997).
Purohit, S.J. et al. Determination of lymphoid cell fate is dependent on the expression status of the IL-7 receptor. EMBO J. 22, 5511–5521 (2003).
Peschon, J.J. et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955–1960 (1994).
Reichlin, A. et al. B cell development is arrested at the immature B cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin β. J. Exp. Med. 193, 13–23 (2001).
Gong, S. & Nussenzweig, M.C. Regulation of an early developmental checkpoint in the B cell pathway by Ig-β. Science 272, 411–414 (1996).
Pelanda, R., Braun, U., Hobeika, E., Nussenzweig, M.C. & Reth, M. B cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-α and Ig-β. J. Immunol. 169, 865–872 (2002).
Schlissel, M.S., Corcoran, L.M. & Baltimore, D. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. J. Exp. Med. 173, 711–720 (1991).
Shang, Y., Hu, X., DiRenzo, J., Lazar, M.A. & Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843–852 (2000).
Dignam, J.D., Lebovitz, R.M. & Roeder, R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475–1489 (1983).